The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

After 30 years as an attorney and more than 11 on the bench, District Judge Mark Johnson retired earlier this month in what ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

In his opening remarks, Idaho Senator Mike Crapo, the Finance committee's chairman, praised Kennedy's “commitment to ...

Johnson & Johnson's fourth-quarter revenues and profit were driven by strong cancer drug sales. The company announced expectations for 2025 earnings to be above Wall Street estimates. However ...

ASHEVILLE, S.C. (FOX Carolina) - The Asheville Police Department reports arresting a man on drug charges after he fled from ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.